Glatiramer acetat (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Glatiramer acetat" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

4nih.gov

4^th place

3^rd place

4web.archive.org

1^st place

3copaxone.com

low place

2doi.org

2^nd place

2fda.gov

447^th place

642^nd place

1sciencedirect.com

149^th place

32^nd place

1wikipedia.org

low place

1hbcpnetbase.com

low place

124^th place

1merckbooks.com

low place

161^st place

1mcgraw-hill.com

low place

132^nd place

1weizmann.ac.il

4,983^rd place

5,904^th place

1mult-sclerosis.org

low place

1iguard.org

low place

1drugs.com

399^th place

1,145^th place

1cochrane.org

7,609^th place

2,670^th place

cochrane.org

„Cochrane Medical review of Copaxone”.

copaxone.com

„Prescribing Information”. Arhivirano iz originala na datum 2007-03-06. Pristupljeno 2014-04-05.
„FDA marketing label”. Arhivirano iz originala na datum 2007-03-06. Pristupljeno 2014-04-05.
„Copaxone marketing materials”.

doi.org

dx.doi.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

drugs.com

„Copaxone Side Effects”.

fda.gov

accessdata.fda.gov

„Full prescribing information copaxone (glatiramer acetate)”.

fda.gov

„FDA Copaxone Label”. Arhivirano iz originala na datum 2003-04-25. Pristupljeno 2014-04-05.

hbcpnetbase.com

Lide David R., ur. (2006). CRC Handbook of Chemistry and Physics (87th izd.). Boca Raton, FL: CRC Press. 0-8493-0487-3.

iguard.org

„iGuard.org TSQM survey results (n=1700+):”. ^{[mrtav link]}

mcgraw-hill.com

books.mcgraw-hill.com

Keith Parker; Laurence Brunton; Goodman, Louis Sanford; Lazo, John S.; Gilman, Alfred (2006). „Chapter 52. Immunosuppressants, tolerogens, and immunostimulants, A case study: Immunotherapy for multiple sclerosis”. Goodman & Gilman's The Pharmacological Basis of Therapeutics (11 izd.). New York: McGraw-Hill. ISBN 0-07-142280-3.

merckbooks.com

Susan Budavari, ur. (2001). The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals (13th izd.). Merck Publishing. ISBN 0-911910-13-1.

mult-sclerosis.org

„www.mult-sclerosis.org”.

nih.gov

ncbi.nlm.nih.gov

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Comi G, Martinelli V, Rodegher M, Moiola L, Bajenaru O, Carra A, Elovaara I, Fazekas F, Hartung HP, Hillert J, King J, Komoly S, Lubetzki C, Montalban X, Myhr KM, Ravnborg M, Rieckmann P, Wynn D, Young C, Filippi M; PreCISe study group. (2009). „Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial”. Lancet. 374: 1503-11. PMID 19815268.
Johnson KP (2010). „Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis”. Ther Clin Risk Manag. volume=15 (6): 153-72. PMID 20421914.
Lackner P., Part A., Burger C., Dietmann A., Broessner G., Helbok R., Reindl M., Schmutzhard E., Beer R. (2009). „Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study.”. Malar J. 8. PMID 19250545.

sciencedirect.com

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

web.archive.org

„The chemistry of the Copaxone drug”. Arhivirano iz originala na datum 2003-09-07. Pristupljeno 2014-04-05.
„FDA Copaxone Label”. Arhivirano iz originala na datum 2003-04-25. Pristupljeno 2014-04-05.
„Prescribing Information”. Arhivirano iz originala na datum 2007-03-06. Pristupljeno 2014-04-05.
„FDA marketing label”. Arhivirano iz originala na datum 2007-03-06. Pristupljeno 2014-04-05.

weizmann.ac.il

„The chemistry of the Copaxone drug”. Arhivirano iz originala na datum 2003-09-07. Pristupljeno 2014-04-05.

wikipedia.org

sh.wikipedia.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit